The average one-year price target for Replimune Group (NASDAQGS:REPL) (DB:7R8) has been revised to $22.44 / share. This is an increase of 14.78% from the prior estimate of $19.55 dated October 20, 2026. These figures represent aggregate analyst targets and do not constitute a rec